Yoshimoto T - Search Results

1

Biology of mouse mammary tumor virus (MMTV).

Matsuzawa A, Nakano H, Yoshimoto T, Sayama K. Matsuzawa A, et al. Among authors: yoshimoto t. Cancer Lett. 1995 Mar 23;90(1):3-11. doi: 10.1016/0304-3835(94)03671-5. Cancer Lett. 1995. PMID: 7720040 Review.

2

Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes.

Matsuzawa A, Yasuda T, Sakamoto S, Nagase H, Nakano H, Yoshimoto T. Matsuzawa A, et al. Among authors: yoshimoto t. Scand J Immunol. 2001 Jun;53(6):553-62. doi: 10.1046/j.1365-3083.2001.00899.x. Scand J Immunol. 2001. PMID: 11422903

3

Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.

Matsuzawa A, Yasuda T, Zhang Y, Nagase H, Yoshimoto T, Kimura M, Tsubura A. Matsuzawa A, et al. Among authors: yoshimoto t. Viral Immunol. 2000;13(3):297-311. doi: 10.1089/08828240050144635. Viral Immunol. 2000. PMID: 11016595

4

Enhancing effect of tumor necrosis factor (TNF)-alpha, but not IFN-gamma, on the tumor-specific cytotoxicity of gammadeltaT cells from glioblastoma patients.

Suzuki Y, Fujimiya Y, Ohno T, Katakura R, Yoshimoto T. Suzuki Y, et al. Among authors: yoshimoto t. Cancer Lett. 1999 Jun 1;140(1-2):161-7. doi: 10.1016/s0304-3835(99)00067-1. Cancer Lett. 1999. PMID: 10403555

5

Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.

Shimizu M, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A. Shimizu M, et al. Among authors: yoshimoto t. Cancer Immunol Immunother. 1998 Nov;47(3):143-8. doi: 10.1007/s002620050514. Cancer Immunol Immunother. 1998. PMID: 9829839

6

Loss of heterozygosity at 11p15 in malignant glioma.

Sonoda Y, Iizuka M, Yasuda J, Makino R, Ono T, Kayama T, Yoshimoto T, Sekiya T. Sonoda Y, et al. Among authors: yoshimoto t. Cancer Res. 1995 May 15;55(10):2166-8. Cancer Res. 1995. PMID: 7743518

7

Deletion mapping of chromosome 10 in human glioma.

Sonoda Y, Murakami Y, Tominaga T, Kayama T, Yoshimoto T, Sekiya T. Sonoda Y, et al. Among authors: yoshimoto t. Jpn J Cancer Res. 1996 Apr;87(4):363-7. doi: 10.1111/j.1349-7006.1996.tb00231.x. Jpn J Cancer Res. 1996. PMID: 8641967 Free PMC article.

8

A trial to kill tumor cells through Fas (CD95)-mediated apoptosis in vivo.

Shimizu M, Yoshimoto T, Nagata S, Matsuzawa A. Shimizu M, et al. Among authors: yoshimoto t. Biochem Biophys Res Commun. 1996 Nov 12;228(2):375-9. doi: 10.1006/bbrc.1996.1669. Biochem Biophys Res Commun. 1996. PMID: 8920922

9

Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.

Nakano H, Yoshimoto T, Kakiuchi T, Matsuzawa A. Nakano H, et al. Among authors: yoshimoto t. Eur J Immunol. 1993 Oct;23(10):2434-9. doi: 10.1002/eji.1830231009. Eur J Immunol. 1993. PMID: 8405042

10

A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.

Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H. Yoshimoto T, et al. Eur J Immunol. 1994 Jul;24(7):1612-9. doi: 10.1002/eji.1830240724. Eur J Immunol. 1994. PMID: 7913038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results